A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 45,400 shares of EWTX stock, worth $817,654. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,400
Previous 64,700 29.83%
Holding current value
$817,654
Previous $708,000 16.95%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$9.25 - $19.97 $178,525 - $385,421
-19,300 Reduced 29.83%
45,400 $828,000
Q4 2023

Feb 13, 2024

SELL
$5.51 - $12.1 $475,513 - $1.04 Million
-86,300 Reduced 57.15%
64,700 $708,000
Q3 2023

Nov 14, 2023

BUY
$5.73 - $7.69 $249,255 - $334,515
43,500 Added 40.47%
151,000 $865,000
Q2 2023

Aug 11, 2023

BUY
$5.71 - $10.29 $61,097 - $110,102
10,700 Added 11.05%
107,500 $833,000
Q1 2023

May 12, 2023

BUY
$6.66 - $11.33 $127,872 - $217,536
19,200 Added 24.74%
96,800 $646,000
Q4 2022

Feb 13, 2023

BUY
$7.58 - $11.08 $146,294 - $213,844
19,300 Added 33.1%
77,600 $694,000
Q3 2022

Nov 14, 2022

BUY
$8.08 - $13.58 $207,656 - $349,006
25,700 Added 78.83%
58,300 $574,000
Q2 2022

Aug 12, 2022

BUY
$5.67 - $9.87 $184,842 - $321,762
32,600 New
32,600 $259,000

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.14B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.